Ex vivo effects of ibogaine on the activity of antioxidative enzymes in human erythrocytes
Mechanisms In vitro moderate
AI-extracted · unverified · confirm at source
Ex vivo ibogaine (10-20μM) elevates SOD1 and GR in human erythrocytes, increases plasma ATP dose-dependently, stabilises SOD1 against H₂O₂ — pro-antioxidant via energy metabolism.
Dosing: 10–20 µM ibogaine HCl (human erythrocytes ex vivo) (not-applicable)
Sample size: 13